Literature DB >> 24189577

Infectious disease: hushing mTOR boosts immunity to pathogens.

Yvonne Bordon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24189577     DOI： 10.1038/nri3562

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  Pathogen signatures activate a ubiquitination pathway that modulates the function of the metabolic checkpoint kinase mTOR.

Authors:  Stanimir S Ivanov; Craig R Roy
Journal:  Nat Immunol       Date:  2013-10-13       Impact factor: 25.606

2.  The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

Authors:  Rachael Keating; Tomer Hertz; Marie Wehenkel; Tarsha L Harris; Benjamin A Edwards; Jennifer L McClaren; Scott A Brown; Sherri Surman; Zachary S Wilson; Philip Bradley; Julia Hurwitz; Hongbo Chi; Peter C Doherty; Paul G Thomas; Maureen A McGargill
Journal:  Nat Immunol       Date:  2013-10-20       Impact factor: 25.606
  2 in total
  4 in total

1.  Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.

Authors:  ChunYu Li; YongPing Chen; XuePing Chen; QianQian Wei; Bei Cao; HuiFang Shang
Journal:  Front Mol Neurosci       Date:  2017-05-30       Impact factor: 5.639

2.  DEPTOR-mTOR Signaling Is Critical for Lipid Metabolism and Inflammation Homeostasis of Lymphocytes in Human PBMC Culture.

Authors:  Qi-Bing Xie; Yan Liang; Min Yang; Yuan Yang; Xiao-Min Cen; Geng Yin
Journal:  J Immunol Res       Date:  2017-02-27       Impact factor: 4.818

3.  Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis.

Authors:  Geng Yin; Ying Wang; Xiao-Min Cen; Yuan Yang; Min Yang; Qi-Bing Xie
Journal:  J Immunol Res       Date:  2017-01-17       Impact factor: 4.818

Review 4.  The Coordination of mTOR Signaling and Non-Coding RNA in Regulating Epileptic Neuroinflammation.

Authors:  Chudai Zeng; Jason Hu; Fenghua Chen; Tianxiang Huang; Longbo Zhang
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.